Clinical Trials Directory

Trials / Completed

CompletedNCT00440570

A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced Tumors

Treatment of Advanced Cancer With Amplitude-modulated Electromagnetic Fields of Low Intensity by Means of an Intrabuccal Probe

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
2 (planned)
Sponsor
Pasche, Boris, M.D. · Individual
Sex
All
Age
18 Years – 95 Years
Healthy volunteers
Accepted

Summary

In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth. We have identified specific frequencies that may block cancer cell growth. We have developed a device delivering low levels of amplitude-modulated electromagnetic fields. The device is connected to a spoon-like coupler, which is placed in the patient's mouth during treatment. We will conduct a feasibility study consisting of three daily ambulatory treatments until disease progression.

Detailed description

Background: In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth. We have identified specific frequencies that may block cancer cell growth. We have developed a portable and programmable device delivering low levels of amplitude-modulated electromagnetic fields. The device is connected to a spoon-like coupler, which is placed in the patient's mouth during treatment. Methods: We will conducted a feasibility study consisting of three daily treatments. All patients with advanced solid tumors and measurable disease will be eligible, irrespective of prior treatments. Patients will be assessed with laboratory exams (complete blood count, comprehensive profile, tumor markers), imaging studies every other month for the first six months, every third month thereafter.

Conditions

Interventions

TypeNameDescription
DEVICELow levels of amplitude-modulated electromagnetic fields
DEVICEEmitter of low levels of amplitude-modulated electromagnetic fields

Timeline

Start date
2004-10-01
Primary completion
2006-09-01
Completion
2007-12-01
First posted
2007-02-27
Last updated
2011-06-29

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00440570. Inclusion in this directory is not an endorsement.